• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Market | Equity | Daily Market Tracker | IPO Synopsis
IPO SYNOPSIS
Rossari Biotech Ltd
Registered Office:
201 A-B 2nd Floor LBS Marg,Akruti Corporate Park Kanjur(W,
Mumbai - 400079,
Maharashtra, India.
Website :  www.rossari.com
Initial Public Offering of 11,676,470 equity shares of face value of (Rs) 2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of (Rs) 425 per equity share (including a share premium of (Rs) 423 per equity share) (the "offer price") aggregating to (Rs) 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to (Rs) 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to (Rs) 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to (Rs) 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to (Rs) 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company. The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to (Rs) 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to (Rs) 150 Crores has been reduced by (Rs) 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to (Rs) 50. Crores
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
13-Jul-20
15-Jul-20
425.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 35     Further Multiples of : 35
 
(Rs.Cr)
Lead Managers to the Issue
Project Cost
0.00
Axis Capital Ltd
Project Financed
496.25
 
Post Issue
10.39
 
Issue Price
425.00
 
Projects
Repayment/Prepayment of certain Indebtedness availed by the company (including accrued Interest)
Funding Working Capital Requirements
General Corporate Purposes
Promoted By
Edward Walter Menezes
Sunil Srinivasan Chari
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd
DB (International) Stock Brokers Limited: SEBI Reg. No.-INZ000179035 / CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Daga Commodities Private Limited: SEBI Reg. No. INZ000028833
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries